CLINICAL_TRIALS
trial_result
· 2024-05-16
Clinical Trial Update: A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis [Phase 3]
Summary
A Phase 3 study comparing CT-P41 and US-licensed Prolia in postmenopausal osteoporosis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celltrion | Conditions: Postmenopausal Women With Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-16